Spectral Medical Inc T.EDT

Alternate Symbol(s): EDTXF

Spectral Medical Inc. is a Canada-based late-stage theragnostic company advancing therapeutic options for sepsis and septic shock. The Company develops and commercializes a treatment for septic shock utilizing its Endotoxin Activity Assay (EAA) diagnostic and the Toraymyxin therapeutic (PMX). PMX is a therapeutic hemoperfusion device that removes endotoxin, which can cause sepsis, from the bloodstream and is guided by the Company’s EAA. PMX is approved for therapeutic use in Japan and Europe and has been used safely and effectively on more than 340,000 patients to date. It has pioneered the development of biochemical markers for the clinical syndrome known as septic shock. It is continuing its legacy business of manufacturing and selling certain proprietary reagents. It develops, produces and markets recombinant proteins, antibodies and calibrators. These materials are sold for use in research and development, as well as in products manufactured by other diagnostic companies.

TSX:EDT - Post by User

Spectral Medical Inc > Here we go again...

<< Previous

Bullboard Posts

Next >>

Post by money4golfon Oct 07, 2023 10:41am

221 Views

Post# 35674499

Here we go again...

Filing Date	Transaction Date	Insider Name	Ownership Type	Securities	Nature of transaction	Volume or Value
Oct 6/23	Oct 2/23	Feigal, David William Jr.	Direct Ownership	Deferred Share Units	56 - Grant of rights	29,565
Oct 6/23	Oct 2/23	Walker, Paul M.	Direct Ownership	Deferred Share Units	56 - Grant of rights	25,379
Oct 6/23	Oct 2/23	D'Alvise, Janelle	Direct Ownership	Deferred Share Units	56 - Grant of rights	35,735
Oct 6/23	Oct 2/23	Stevens, William Charles	Direct Ownership	Deferred Share Units	56 - Grant of rights	30,114
Oct 6/23	Oct 2/23	Bihl, Anthony Phillip	Direct Ownership	Deferred Share Units	56 - Grant of rights	62,728